On Tuesday, the Food and Drug Administration (FDA) announced it will not approve any generic versions of the original form of OxyContin. A move that officials hope will prevent prescription drug abuse, Reuters reports.
In its original form OxyContin could easily be crushed and then snorted or injected.The FDA approved new labeling for a reformulated version of the drug, a label that indicates that OxyContin is more difficult to crush making it harder to abuse than the original version. OxyContin’s manufacturer, Purdue Pharma, introduced the tamper-resistant formula in 2010.
“The development of abuse-deterrent opioid analgesics is a public health priority for the FDA,” Douglas Throckmorton, MD, Deputy Director for Regulatory Programs in the FDA’s Center for Drug Evaluation and Research, said in a statement. “While both original and reformulated OxyContin are subject to abuse and misuse, the FDA has determined that reformulated OxyContin can be expected to make abuse by injection difficult and expected to reduce abuse by snorting compared to original OxyContin.”
Representative Hal Rogers of Kentucky, Co-Chairman of the Congressional Caucus on Prescription Drug Abuse, said, “This is a huge win for our region and for the thousands of families who have seen painkillers become pain makers. The FDA undoubtedly saved our nation from another deadly tidal wave of oxycodone abuse and overdoses.”